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ABSTRACT
Clinical trials have demonstrated the therapeutic benefits of adding radiofrequency (RF) hyperthermia
(HT) as an adjuvant to radio- and chemotherapy. However, maximum utilization of these benefits is
hampered by the current inability to maintain the temperature within the desired range. RF HT treat-
ment quality is usually monitored by invasive temperature sensors, which provide limited data sam-
pling and are prone to infection risks. Magnetic resonance (MR) temperature imaging has been
developed to overcome these hurdles by allowing noninvasive 3D temperature monitoring in the tar-
get and normal tissues. To exploit this feature, several approaches for inserting the RF heating devices
into the MR scanner have been proposed over the years. In this review, we summarize the status quo
in MR-guided RF HT devices and analyze trends in these hybrid hardware configurations. In addition,
we discuss the various approaches, extract best practices and identify gaps regarding the experimental
validation procedures for MR - RF HT, aimed at converging to a common standard in this process.
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Introduction
Hyperthermia (HT) treatments involve heating tissues to the
range of 40–44 C for 60–90min [1]. The majority of the HT
treatments are applied using external devices employing
radiofrequency (RF) electromagnetic waves [2,3]. Clinical trials
have shown that RF HT improves clinical outcome, without
adding to the toxicity, of radiotherapy and a number of che-
motherapies [4–6]. Clinical work showed that intra-tumoral
temperatures are correlated with clinical outcome parameters
such as local control of tumors [7–15]. Due to the body’s
strong, inhomogeneous and variable thermoregulation
[16–19], close monitoring of the temperature is required to
optimize the power distribution accordingly. Here, the goal is
to focus energy at the target region and prevent unwanted
hotspots in normal tissues. Several different approaches for
noninvasive thermometry, like impedance tomography,
active and passive microwave imaging, CT, laser, infrared,
ultrasound, MR-techniques, have been investigated in the
last decades. Among all these different techniques, MR
thermometry (MRT) has been elaborated most extensively
and validated in clinical and experimental settings [20,21]. In
addition, the gantry of the current MRI systems provides the
possibility for mechanical integration with hyperthermia
applicators [22]. MR imaging also provides the possibility to
image the complete treatment setup, i.e., patient surrounded
by the applicator, as well as monitoring perfusion/tissue
cooling and the response to treatment. To enable all the
aforementioned benefits of using MRI with RF hyperthermia
devices, the compatibility of these devices with the MRI sys-
tem (‘MR compatibility’) is crucial, especially in terms of how
they impact image quality. These properties are often not
quantified and reported in a standardized way for interven-
tional devices. An overview of such systems and an inventory
of the required image quality metric is, however, currently
lacking.
The important potential benefits of noninvasive thermom-
etry can be highlighted best when compared to invasive
thermometry, which is the current golden standard for intra-
tumoral temperature assessment during RF HT therapy. In
invasive thermometry, temperature probes are inserted into
closed-tip catheters and placed in body cavities or pierced
into tissue. Invasive thermometry can be done using com-
mercially available types of thermocouples and thermistors
suitable for use in clinical hyperthermia. Available thermistors
are the Bowman thermistor probe [23] (BSD Medical Corp.,
Salt Lake City, UT) and the fiber-optic (FISO) thermistor probe
(gallium arsenide (GaAs) [24] and fluorescence (fluoroptic)
[25] probes). Thermocouples and the Bowman thermistor
probes rely on detection of a voltage and fiber-optic probes
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rely on the temperature dependency of band gap and refrac-
tion index. The reported accuracy of the fiber-optic and bow-
man probes are better than ±0.1 C and ±0.2 C, respectively,
taken from datasheets by the manufacturer. Although accur-
ate, such thermometry provides very limited spatial informa-
tion, i.e., only along the line of the catheter. Specifically, for
RF HT treatment where a large volume is heated, the prob-
ability that invasive thermometry detects all the hotspots of
interest is low. This is due to the limited number of tempera-
ture probes, and clinical restrictions for placement of therm-
ometry catheters. In addition, probe insertion may be painful
and hazardous. Complications such as infection or neuro-
logical complaints and other discomfort were observed along
with a low acceptance in patients and physicians [26,27].
Therefore, MRT has the potential to replace the invasive
thermometry in the clinic because of its noninvasive nature,
high spatial resolution and 3-dimensional (3D) anatomical
coverage per unit time.
The first decade after the advent of MRT was devoted to
developments in techniques allowing temperature assess-
ment during thermal therapies [28–32]. Several temperature-
sensitive parameters were studied, like the proton-resonance
frequency shift (PRFS), apparent diffusion coefficient (ADC),
longitudinal relaxation time (T1), transversal relaxation time
(T2), and equilibrium magnetization (M0) [33–35]. Of these
endogenous temperature indicators, techniques that leverage
the PRFS effect observed in water-rich tissue have been
studied more extensively [33,34,36]. This technique is based
on the fact that the change in image phase in a pair of gra-
dient echo images acquired at two different temperatures is
linearly proportional to the temperature change. This arises
from a proton resonance frequency that linearly decreases as
temperature increases in the water molecule (0.01 ppm/C)
[37]. The second decade saw the development of techniques
that enabled more robust and reliable results, especially for
in vivo applications [38–41]. However, the PRFS effect is small
and, thus, is highly sensitive to magnetic field perturbations,
which degrade MR thermometry accuracy. Such degradation
is especially pronounced in long duration hyperthermia treat-
ments (90min). These magnetic field perturbations may be
caused by a number of possible mechanisms that manifest
themselves differently. For example, gradient-induced heat-
ing of passive shim elements may cause non-periodic tem-
poral B0 drift that vary smoothly in space across the imaging
field-of-view, while patient respiratory/cardiac motion may
induce periodic B0 perturbations in a local region, especially
near interfaces of tissues that have different magnetic sus-
ceptibility values. Non-periodic and local B0 perturbations
may also arise from intestinal/bowel movement. The removal
of these temporal field perturbation effects is crucial for suc-
cessful MRT for thermotherapy monitoring, and the different
variants of B0 perturbation may require different types of
correction methods. The inherent signal-to-noise-ratio (SNR)
of MR signals is another very important quantity that impacts
the accuracy and robustness of MRT.
For MR-guided radiofrequency hyperthermia (MRgRFHT),
the RF body coil in the MRI scanner is typically used to
receive MR signals for MRT since HT devices are not
designed to allow the concurrent placement and use of com-
mercial MR flexible coils. Hence, the SNR available is rela-
tively low since the RF body coil is positioned much further
from the region of interest (ROI) compared to a surface coil
array that could have been placed in close proximity to the
patient. Moreover, RF body coils in commercial MRI scanners
can only receive MR signals in single (quadrature) channel
mode and thus do not exploit parallel imaging for scan time
reduction. To address this problem, new hardware designs
are being researched to improve SNR and enable MR parallel
imaging, while simplifying and reducing equipment footprint
(physical space that a device occupies). This can increase the
reliability of MR-temperature measurements and improve
patient access to MRgRFHT in the clinic.
The purpose of this paper is to analyze all research work
done in the space of MRgRFHT, and review the status in
terms of device validation, preclinical investigations and clin-
ical trials. In this analysis, we excluded papers on devices
aimed at thermal ablation and those focused on MR therm-
ometry techniques and algorithms. The current review
attempts to review the scope of technical advances in MRI
guided RF HT for new scientists, clinicians and other profes-
sionals and provide the groundwork for improved validation
by summarizing and proposing standards on its reporting.
Materials and methods
We performed a literature search in the Scopus and the Web
of Science (WoS) databases using the following search
strings:
TITLE-ABS-KEY [(((‘magnetic resonance’ OR mr) AND therm-
ometry) OR ‘thermal magnetic resonance’ OR ‘thermal mr’ OR
‘temperature imaging’) AND ‘hyperthermia’
OR
TITLE-ABS-KEY (hyperthermia AND mri) AND (clinical OR
preclinical) AND (evaluation OR validation OR verification)]
AND
TITLE-ABS-KEY (hybrid OR integrated OR hardware OR
configuration OR setup OR ‘set-up’ OR system OR device OR
applicator OR prototype OR platform)
where TITLE-ABS-KEY indicate either the title, abstract or key-
words of the paper. This resulted in 325 articles (249 in Scopus
and 76 WoS). The duplicated results in the two databases were
removed. We further added 4 articles that were not found in
the structured literature search and 2 conference abstracts that
were not available in the Scopus or WoS databases.
Two exclusion steps were then introduced for selecting
only papers concerning RF-HT (exclusion criterion 1) and ori-
ginal papers (exclusion criterion 2). The selection process is
summarized in Figure 1.
In exclusion criterion 1, all papers were excluded having
TITLE-ABS-KEY on the following:
 Ablation
 Non-RF HT, e.g., HIFU/Laser studies
 Methodology, algorithm (e.g., theory of temperature mon-
itoring and resolution, evaluation of temporal spatial
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resolution, estimation and correction of induced errors
due to breath or organ displacement (motion)).
Application of exclusion criterion 1 reduced the number
of papers to 106 articles (85 Scopus 19 WoS and 2 confer-
ence abs) after reading title-abstract and to 57 articles (46
Scopus, 9 WoS, and 2 conference abstracts) after reading the
full text. This selection comprised the relevant papers on MR
guided RF-only HT devices.
Exclusion criterion 2 intended to only include original
studies which presented novel design and prototypes.
Articles including the following were excluded:
 Review articles
 Non-English language articles
 Book series or only insufficient abstracts available
After exclusion criterion 2, 46 papers (39 Scopus, 5 WoS,
and 2 conference abstracts) remained presenting or investi-
gating novel hybrid MRgRFHT devices. These devices are
categorized in the next section and summarized in Table 1.
In this work, we defined quantitative validation as the agree-
ment between the measured quantities in MRT versus a gold
standard technique, e.g., average error between MRT and
invasive probe measurements. Those papers reporting only
the quality of the agreement as an impression or distribu-
tion, i.e., quantifying only the shape and size of the heated
zones in the MR images, were scored as qualitative.
MR-guided RF HT devices
Various approaches aiming to integrate RF-HT applicators
and MRI system have been proposed and can be roughly
categorized into (1) decoupled systems (HT-only inserts); (2)
integrated systems (Dual-function inserts).
Decoupled devices (HT-only inserts)
These devices are based on an independent RF transmission
chain and an RF-HT applicator insert that operates inside the
bore of a MRI scanner. Since such hyperthermia devices
operate independently from the MR system, heating and
imaging can be performed simultaneously. Unless mentioned
otherwise, the MRI scanner’s RF body coil is used for both RF
transmit and receive of the MR signals. Such developed devi-
ces are:
Noninvasive clinical setups
– BSD2000-3D-MRI applicator is the only MR-guided RF HT
device that has led to a commercial prototype, in combin-
ation with 1.5 T MRI systems. This applicator consists of 12
dipole antenna pairs operating at 100MHz, arranged on
three rings of four dipole pairs each, that are independently
controlled to steer the energy focus toward deep seated
tumor volumes. This device has been validated both preclini-
cally [40,42–44] and clinically [45,46]. A systematic compari-
son of 3D-specific absorption rate (SAR) distribution between
MRT and planning calculations in a homogenous cylindrical
and heterogeneous elliptical phantom demonstrated a devi-
ation in the range of 2–3W/kg, i.e., below 10% [43]. The pos-
sibility to adapt/optimize SAR pattern in a phantom by
employing MR thermometry in an iterative procedure were
also shown for this applicator [47]. A recent more systematic
quality assurance analysis of this system in a 1.5 T MRI scan-
ner showed a mean maximum temperature increase (Tincrease,
max) in a Perfax homogeneous phantom of 5.9 ± 0.4 C, using
1000W input power for 12.4min, and a mean steering error
of 0.4 ± 0.2 cm [44]. Clinical experiments in 15 patients [46]
with pre-irradiated rectal recurrences showed significant cor-
relation between the MRT-derived mean temperatures in the
tumor with invasive measurements, tumor features (volume
and location) and clinical response (p¼ 0.04) [46].
– The mini-annular-phased array (MAPA) RF HT applicator
is the only other applicator which has been used on patients.
The MAPA consists of four pairs of flared dipole antennas
and was designed to treat limb tumors in extremities and
modified for insertion into MRI scanner [48]. Usually a single
frequency (140MHz) and signals of equal amplitude and
phase have been used. Hybrid operation was validated by
inserting the MAPA into a 0.5 T whole body MRI system and
its head coil during synchronous heating and imaging
[32,48,49]. In these studies, diffusion coefficient based tem-
perature imaging methods were used to monitor tempera-
tures in a gel based phantom. Temperatures in 1 cm2 regions
of interest were found to be within 0.2 C from invasive
measurements. Clinical validation was performed in 4
patients with high-grade primary sarcoma tumors of the
lower leg [50] and 10 patients with high grade extremity soft
tissue sarcomas [51]. On the tumor ROIs, the mean difference
Figure 1. Selection process for inclusion of papers with criteria reported in
the text.
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between PRFS-MRT and interstitial point measurements was
0.62 C in steady state.
– The MRlabCollar is an MR-compatible laboratory proto-
type of the HYPERcollar3D HT applicator consisting of two
rings of six patch antennas operating at 434MHz. Pilot meas-
urements by Numan et al. (2013) using the lower half of the
original LabCollar showed an average PRFS-MRT accuracy of
0.4 C (0.1–0.7 C) against fiber-optic probe thermometry [52].
Heating size and shape had a good correlation with predic-
tions (R2¼ 0.76). Paulides et al. (2014) introduced the design
of an MR compatible head and neck laboratory prototype
applicator and showed the focused heating capabilities of
MRlabcollar [53]: a maximum SAR of 100W kg1 and a tem-
perature increase of 4.5 C in 6min was feasible using 300W
input power in a cylindrical fat/muscle phantom. The central
heated region in this phantom corresponded very well to
those obtained earlier by infrared measurements in a
muscle-only split-phantom phantom for the setup without
MR compatibility feature (LabCollar) [54]. This device was
again validated pre-clinically in an oil–gel phantom by apply-
ing a combination of MR imaging and 3D spline fitting for
accurate probe localization [55]. The result corresponds to a
reduced average error of DT< 0.14 C with a maximum error
of DT¼ 0.22 C.
– The MRCollar, the clinical implementation of the
MRlabcollar, consists of 12 dielectric parabolic reflector
antenna (DIPRA) modules, i.e., parabolic water-filled encas-
ings around printed reflector-backed dipole antennas [56].
Two arrays of six antenna structures were placed in two
semi-circular structures. By electromagnetic simulations, the
authors showed that the power focusing ability of the device
in terms of the target coverage of the 25% iso-SAR contour
(TC25) is 83.7 ± 15.6% for head and neck tumors in clinic. A
reduced scale phantom experiment demonstrated that only
very localized image distortion was observed. MR imaging
was obtained using the body coil of 1.5 T MRI scanner.
– Capacitive: a two-channel capacitive RF heating system,
consisting of four electrodes operating at 26MHz, was eval-
uated on a phantom aiming to heat a deep-seated target
region in which electrical conductivity was elevated by nano-
particle mediation [57,58]. When one electrode pair was acti-
vated, the other electrode pair was electrically isolated to
prevent RF current leakage between the electrodes. MRT,
using a 3 T MRI sequentially with the RF heating, showed
maximum DTave< 0.5 C relative to fiber-optic measurements
after phase error correction in the center of the phantom.
Using this system, Hernandez et al. (2016) proposed a correc-
tion method of B0 drift effects in MR thermometry [59], for
which they placed magnetic field monitoring (MFM) probes
around the subject to compute phase correction maps for
MRT by interpolating the center frequencies of MFM signals
on the imaging slice. Using phantom measurements, the
authors showed that this B0 drift correction reduced the
mean squared temperature error of MR thermometry to an
average of 0.47 C. This device is the only capacitive MR
guided RF HT device and the only system that used MFM
probes instead of fat references for B0 field drift corrections.
– The current sheet antennas (CSA) is a phased array con-
sisting of two identical MR-compatible current sheet anten-
nas operating at 100MHz. Hoffmann et al. (2002) used CSA
for heating a tissue-equivalent phantom inside a 3 T MRI
[60]. The heating capabilities were measured with PRFS
method in sequential heating and imaging experiments. The
maximum error between the MR-derived and fiber-optic
measured temperatures was estimated to be ±1 C and the
SD was 0.4 C. This development has not translated into a
clinical product.
– The clinical WACOA applicator (CWA) is a HT applicator
consisting of 12 separate WAter COated Antenna (WACOA)
modules operating within a 1.5 T MRI scanner. The modules
are designed as MR-compatible, specially shaped and adjust-
able, cylindrical dipole structures embedded into hermetically
closed cassettes filled with deionized water. Experimental
and numerical evaluations demonstrated that the CWA is
able to steer the 3D temperature pattern [61]. In 2005, the
device was evaluated by a 3D comparison of predicted and
measured temperature data sets for an inhomogeneous
phantom [62]. The average error of the calculated versus
measured temperature comparison was 0.45 C. CWA was
the first device which had its numerical model validated with
3D MR-temperature measurements, but it was not translated
into a clinical version.
– The hexagonal flared-type whole body phased array
applicator operates at 130MHz and consists of 3 pairs of
flared dipole antennas. The root mean square (RMS) and
average difference between the MR-derived temperatures
(1.5 T) and probe temperatures in phantom were 1.23 C and
0.92 C, respectively [63]. The standard error of the mean
temperature change was found to be 0.22 C in a 50mm3
region of a gel phantom for echo time of 20ms [64]. The
group also performed in vivo experiments to evaluate the
ability of MRT in canine brain and muscle [64–66]. The results
showed a standard error of 0.6 C in a 16mm3 volume for
brain tissue and muscle tumor (sarcoma) [64].
Invasive clinical setups
– The intravascular MRI guidewire is an interstitial system that
simultaneously produces RF heating and high SNR imaging/
temperature mapping used for enhancement of vascular
gene transfer. The system consists of MRI guidewire placed
within the guidewire channel of a gene delivery catheter and
is connected to an 1.5 T MR scanner and external RF gener-
ator/amplifier through a filter box [67]. The system was vali-
dated both in vitro (cylindrical phantom, qualitative
validation) and in vivo (in the aorta of rabbits). For the
in vivo experiment, the SD error between the MR-derived
temporal curve and that of the fiber-optic measured tem-
perature curve was 1.2 C. Moreover, the maximum tempera-
ture increase in target aortic wall was approximately 7 C
from a baseline temperature of 37 C using 4–5W input
power for about 4min. The intravascular MRI guidewire was
the first device that used the same antenna for RF heating
and MR imaging in a simultaneous operation.
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Preclinical (animal) setups
Preclinical setups are small and flexible in comparison to
conventional HT systems and generally combined with ultra-
high field preclinical MRI systems. The antennas predomin-
antly operate at 2.45 GHz.
– The Slot&Dipole applicator by Demura et al. (2006) are
two MR-compatible microwave applicators operating at
2.45GHz of dipole-type and slot-type and evaluated using
phantoms and living animals [68]. A 10-mm-deep area could
be heated at an average target temperature of
42.60 ± 0.14 C and a skin surface temperature of
43.27 ± 0.45 C, using 60–110W input power intermittently
(2 s power-on, 2 s power-off) for 60min experimental period.
The 95% limits of agreement between MR and fluoroptic
thermometry in the three rabbits were þ0.318/0.339 C,
þ0.693/0.661 C, and þ0.564/0.526 C, respectively.
– The coaxial applicator incorporates a 3.5mm directional
microwave antenna operating at 2.45GHz designed for small
animal investigations inside the 30mm bore of the 14 T ultra-
high field MRI scanner [69]. Simulations and experiments in
tissue mimicking phantoms demonstrated the feasibility of
heating 21–982mm3 targets to temperature rises of
Tincrease> 3 C at radial distances up to 6mm from the
applicator, with 8–12W input power. DTmax between MR
thermometry and fiber-optic temperatures was 0.6 C. In
vivo experiments demonstrated the feasibility of delivering
HT to implanted tumors in two experimental mice in com-
bination with PRFS based MRT [69]. 4 C and 11 C tem-
perature increase were achieved with 20W microwave
exposure for 5min and 15min, respectively.
– The Yagi-Uda-based small animal HT applicator operat-
ing at 2.45 GHz was designed and validated by Raaijmakers
et al. (2018) for superficial HT in small animals in a 7 T MR
scanner [70]. The antenna was based on an earlier designed
MR-compatible Yagi–Uda antenna presented by Paulides
et al. (2017) [71]. The antenna was designed for a low MR-
footprint and directional radiation properties to minimize
inter-element coupling for typical array configurations (S21 <
23 dB). Validation in a homogenous muscle phantom
showed PRFS-MRT to correlate with temperature probe
measurements (root mean square error: RMSE ¼ 0.51 C and
R2 ¼ 0.99) and the ability to create a small heating focus
(<1 cm3) in an animal-sized muscle-mimicking phantom. The
applicator was mechanically redesigned by reducing the dis-
tance between antenna arms and the target [72] to reduce
losses in the deionized water (severe at 2.45GHz) between
antenna and animal. In vivo experiments in leg tumors of
four nude mice showed a DT of 7 C in 5min using 7W
power and no artifacts were observed in the MR images dur-
ing simultaneous heating and imaging.
– The Annular-phased Array (APA) is composed of six
dipole antennas for heating deep seated regions of the
body. Kowalski et al. (2002) proposed a phase/amplitude
optimization technique using only information from MRT
[73]. Preclinical validation of the device, operating at
915MHz, was performed by heating a homogeneous cylin-
drical phantom [73,74]. The applicator and phantom were
placed inside an MRI birdcage coil, and the entire assembly
was inserted into a 4.7 T MRI magnet. Fluoroptic probe meas-
urements demonstrated control of the heat focus position
employing only MRT-based temperature feedback informa-
tion. The APA is the only applicator where the ultimate goal
of MRgRFHT, i.e., control of the temperature distribution
based on MRT, was realized during a phantom heating
experiment.
Dual-function devices
These devices use the same antenna array for heating and
imaging. When the MRI RF body coil is used for imaging,
problems such as inter-system cross-talk, signal oscillations
and low image SNR arises. Dual-function devices overcome
these limitations since they only have a single system, they
have multichannel antenna operation and the antennas are
closer to the target for higher signal pickup. However, since
these devices require interleaved operation, simultaneous
operation cannot occur.
Electronic switching
These devices consist of a single set of conductive struc-
tures that can alternately be used for MRI receive and RF
heating using fast electronic switches. The two possible
implementations use either the scanner’s RF transmit chain
for heating at the Larmor frequency or a separate transmit
chain to apply RF energy at a different frequency. Inter-sys-
tem coupling and RF HT equipment footprint is theoretic-
ally smaller in such devices compared to decoupled two-
system configurations. Yeo et al. (2011) introduced one
such device operating at 128MHz (Larmor frequency at 3 T),
which switches between a loop coil array for MR imaging
and a C-shaped dipole antenna array that generates
focused electric fields for RF heating via selective inclusion/
exclusion of impedance matching and tuning capacitors
using fast RF switches [75]. The results indicated that C-
shaped dipole antenna arrays can induce steerable heating
similar to straight dipole antenna arrays. The loop coil array
functions as a 3 T MRI RF receiver that yields an imaging
SNR that is about three times higher than that of an RF
body coil. Therefore, C-shaped dipole antenna arrays could
potentially enable 3D heat steering and MRI with the same
physical hardware.
Thermal MR
Another approach, designated as ‘thermal MR’, allows RF
heating and MR imaging application using the same antenna
array and the power amplifier of the MR system. Here, part
of the regular imaging sequence time, e.g., the last 10%, is
used to apply RF for heating. This approach is particularly
effective in MR scanners at ultra-high magnetic fields ( 7 T)
for which the Larmor frequency approaches the optimum
frequency for semi-deep heating [76,77]. The advantage of
the pulse modulated signal used for RF HT and MRT is the
ability to modify the imaging technique in order to perform
RF HT and MRI at the same frequency without the need for
electronic switching which further reduces the dead time for
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contemporaneous operation. In addition, the electric fields
for imaging and heating are equal, thus, in vivo quality assur-
ance can be applied using B1þ imaging as a surrogate for
the electric field induced in the patient. One such device is
an 8-channel transmit/receive (Tx/Rx) hybrid RF applicator
consisting of bow-tie dipole antennas (‘dual function bowtie
array’) that generate an E-field pattern for RF heating and a
circular polarized H-field for MRI [76]. Each channel has inde-
pendent control of phase and amplitudes. The applicator
was connected to the MR system via a coil interface compris-
ing 8 Tx/Rx switches.
In 2015, Winter et al. presented the preclinical results
derived from the same applicator at 300MHz using a cylin-
drical phantom mimicking brain tissue with the size of a
human head [77]. The experiments demonstrated that the
pulsed multi-channel transmit system of a 7 T MR scanner
supports targeted RF heating and provides enough power
(Pavg > 400W) to induce a temperature increase of 11 C in
3min in the center of a head sized phantom.
Discussion
The purpose of this comprehensive review article is to inform
scientists, clinicians, engineers, and hardware professionals of
the state-of-the-art in MRgRFHT devices to potentially accel-
erate technical and clinical investigations in this space. Our
literature search shows that an increasing number of groups
are investigating approaches to apply HT under MR guidance
(Figure 2). Although most of the devices developed (Table 1)
have not been evaluated in the clinic, multiple in vivo experi-
ments demonstrated the maturity of MRT for clinical applica-
tions. Especially, for the BSD and MAPA applicators, the
results of clinical validations show a high correlation
between MR-derived temperature and invasive probe meas-
urements. However, these results were obtained in anatom-
ical regions where MR signals were minimally affected by
motion, i.e., distal from tissues impacted by moving air in
intestines, cardiac, bowel, and respiratory motion. Hence,
improved motion robust MR thermometry approaches for HT
are still highly warranted.
In our list, 10 devices were intended for clinical use.
However, only two of them were actively used in the clinic
(BSD2000-3D-MRI, MAPA), and only the BSD2000-3D-MRI is
commercially available. Both of these applicators operate in
a 1.5 T MRI system. This is convenient since 1.5 T systems are
cheaper and more available than the 3 T systems.
Furthermore, it is easier to filter the high-power RF hyper-
thermia signals (100MHz or 140MHz) from the 1.5 T RF trans-
mit/receive signals (64MHz) compared to the 3 T RF signals
(128MHz) during simultaneous RF hyperthermia treatment
and MR imaging. Dual function devices by design do not
have to tackle this issue. Higher field strengths are also pref-
erable because the Larmor frequency approaches the opti-
mum heating frequency, which is between 150 and 300MHz
in the pelvic region and between 300 and 915MHz for head
and neck and extremities [78]. After the early feasibility stud-
ies of diffusion-based MR thermometry methods, PRFS-based
MRT methods were used in all studies. Spoiled gradient echo
sequence with echo times close to the T2 of muscle tissue
is commonly used for PRFS-based MRT scans [44,49,
60,62,64,68]. In addition to treatment monitoring, MRT also
provides unique opportunities to validate EM models with
3D measurements. Validation by MRT was only utilized for
the BSD, MRlabcollar, CWA, and dual function bowtie array
applicators.
The MR compatibility of complex assemblies like RF
hyperthermia arrays coupled to waterbolus structures is
often difficult to achieve. In addition, MR-compatible applica-
tors are typically less efficient and controllable in comparison
to the corresponding applicators outside MRI. Since MR com-
patibility requires the use of non-magnetic components,
many off-the-shelf connectors, baluns (required to go from
unbalanced coax to a balanced dipole) and matching net-
work approaches cannot be used. The circulatory movement
of water in the water bolus often generates MR image
artifacts. Consequently, the efficiency and the capability to
control the RF heating pattern might be compromised in
MR-compatible applicator types. On the other hand, the
availability of 2D/3D MRT temperature maps now provides a
unique opportunity to improve and optimize the treatments.
If MRT cannot be utilized to improve thermotherapies, MR-
compatible applicator types will only be useful for accurate
modeling of treatment setup.
Reporting of validation results
Comparing the performance of these devices is currently not
straight-forward. This stems from the fact that, there is a lack
of general metrics for quantitative and qualitative validation
of MRgRFHT devices. In several cases, performances of devi-
ces were reported in vague terms such as ‘reasonable corre-
lations’ and ‘relatively comparable’. As the data in Table 1
show, different investigations reported different goals and
metrics for the validation. Out of 25 clinical and pre-clinical
validation experiments for 15 reviewed devices, 12 contain
reports on heating ability (7 quantitative and 5 qualitative
validations), 12 on MR compatibility (1 quantitative and 11
qualitative validations) and 20 on MRT accuracy (18 quantita-
tive and 2 qualitative validations).
In our view, validation of an MR-guided RF HT device can
be broken down into three distinct topics: heat focusing and
steering, MR compatibility, and MRT accuracy. Based on our
review, we extracted and recommended metrics for stand-
ardization of the validation (Table 2).
First, an RF HT device’s ability to apply heat in a targeted
manner may be characterized by minimum hot spot size,
steerability of hot spots, and spatial conformality of heated
regions to some desired region. Metrics to describe these
qualities may be defined in terms of temperature rise or SAR.
Second, the devices interaction with the MR environment,
i.e., MR Safety and MR compatibility, should be assessed. The
test methods for MR safety have been identified by commit-
tees [79–82] but there is currently no set of tests for MR
compatibility. We recommend that a device’s effect on B0
homogeneity, B1þ homogeneity, and SNR should be meas-
ured for MR compatibility assessment. To that end, image
20 F. ADIBZADEH ET AL.
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SNR [83–86] and geometric distortions [87,88] should be
quantified. Furthermore, sufficient decoupling between MRI
RF frequency and HT RF frequency (and its harmonics and
parasitic frequencies) needs to be demonstrated. Lastly, the
validation of MR thermometry should be quantified as the
difference between the MR-derived versus invasive measured
temperature increase for various probe sensor points based
on National Institute of Standards and Technology (NIST). For
experiments that involve the use of phantoms, the phan-
tom’s dimensions, shape, material, and probe locations
should be reported. In the case of in vivo experiments, the
number of subjects, region of interest, pathology type, and
probe insertion locations should be reported, where applic-
able. For all MRI-based measurements, the MRI pulse
sequence type, scan parameters (e.g., echo time, repetition
time, flip angle, matrix size, slice thickness, field of view, total
acquisition time, etc.) should be reported.
The further development of MRgRFHT
Future work will aim to improve thermotherapy delivery per-
formance by enabling more accurate temperature monitor-
ing with dedicated sequences and post processing
techniques that mitigate artifacts, e.g., motion. Accurate tem-
perature monitoring enables to adjust the SAR for better tar-
geting the heat into the tumor area. New hardware solutions
are urgently needed to simplify and reduce equipment pro-
file to increase patient access to MR-guided RF HT in the
clinic, e.g., low-profile liquid bolus for permittivity matching
and cooling, and dual-function integrated MR-RF HT applica-
tors for improved SNR in MR thermometry.
An excellent potential of using a single integrated
antenna array structure for dual-function devices has been
demonstrated in the literature. However, that approach is
hampered by (1) the need for sequential heating and imag-
ing, and (2) potentially contradicting requirements in terms
of frequency and coil/antenna design. Decoupled devices
have the benefit that different frequencies can be used for
imaging and heating, which enables (1) simultaneous oper-
ation and (2) the possibility of exploiting optimal heating fre-
quencies regardless of the imaging frequency. Another
benefit of the latter approach is that it allows RF HT to be
applied on the most commonly available MRI field strength
in the clinic (1.5 T) today, which can potentially increase
patients’ access to RF HT and lower operational costs. Hence,
accessibility of electronic switching and thermal MR
approaches are strongly dependent on the progress in the
clinical availability of scanners based on 3 T, 7 T or beyond.
The ability to quickly reconfigure the setup of an MRI
scanner from RF hyperthermia treatment to standard diag-
nostic imaging mode, and vice versa, is also important in a
clinical setting. This is especially if the clinic aims to maxi-
mize patient throughput on the scanner, regardless of
whether it is used for therapy or diagnostic imaging. Thus,
the RF hyperthermia equipment and associated software
needs to be configured such that a quick change between
diagnostic and interventional modes of an MRI scanner canTa
bl
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be made. This may involve dedicated scanner tables and
software for diagnostic versus therapy modes.
The current clinical application of MR guided RF hyper-
thermia is strongly hampered by motion, heterogeneities,
clips, and physiological changes (bladder filling, perfusion,
swelling). The major problem with the PRFS (used in most
cases) is the strong disturbance by motion and heterogene-
ities. Other MR parameters (T1 or T2) might be better suit-
able since these are less sensitive to motion, and motion
correction techniques like gating could be applied. Note that
many of these techniques are studied in the context of ther-
mal ablation [89–91], but application for the range of
40–44 C still has to be studied. For all methods, increasing
SNR is highly warranted since this allows for faster scanning
and/or more accurate measurements. We foresee that clinical
translation of the novel applicator approaches reported in
this review will provide big steps toward achieving sufficient
SNR as groundwork for accurate MRT in the clinic. This, in
turn, will aid in the development of more precise heating
devices and truly, i.e., MRT feedback controlled, application
of MRgRFHT.
Conclusion
In conclusion, on-line noninvasive 3D MR thermometry (MRT)
offers very valuable information about the tumor and normal
tissues to improve treatment planning, treatment monitoring
and assessment of treatment effectiveness. The results
obtained thus far from the MR-guided RF HT devices
Table 2. Summary of proposed validation stages and metrics for standardization of the validation of MRgHT devices.
Topic Sub-topic Quantification metric
Heating ability Focusing Option 1: Ttarget, increase
Option 2: SARmax for 1 W input power
Option 3: 50% iso-SAR contour
Focus steering Option 1: relocation of maximum heating point (mm)
Option 2: relocation of center of the 50% iso-SAR contour (mm)
Compatibility B0 No standardized metrics were found in literature.
Proposal: average and maximum DB0 changes with/without the RF HT device present
B1þ No standardized metrics were found in literature.
Proposal: average and maximum DB1þ changes with/without the RF HT device present
Decoupling No standardized metrics were found in literature.
Proposal:
Option 1: Coupling between the systems (S-matrix).
Option 2: Image quality degradation metrics during contemporaneous operation of MRI and RF HT
Image noise Image signal to noise ratio (SNR)
Geometric distortion DICE score, normalized cross-correlation of landmarks in calibration phantoms
MRT accuracy DT Accuracy Root mean squared error (RMSE)
DT bias and precision Mean error (ME) and Standard error (SE)
Correlation Coefficient of determination (R2) and probability (p-value)
Figure 2. The number of publications over years after applying the search string and exclusion criterion 1 provided in the text (Material and methods). An
increased number of publications on MR-guided RF HT (red bars) can be seen after 2001 (development of the BSD2000-3D-MRI) and after 2014 (development of
the MRlabcollar and Thermal MRI).
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described are very promising, and MRT during RF HT treat-
ment has been demonstrated to be feasible in selected
cases. Still, improvements are highly warranted to enable
MRT guided treatment and treatment optimization in more
anatomical locations with greater robustness to motion-
induced artifacts. Technical advances during recent years
may provide promising solutions to overcome many of the
technical obstacles such as poor temperature measurement
accuracy, low temporal resolution and low imaging SNR.
Unfortunately, it is difficult to truly compare the advances
since very little standardization was observed in the ongoing
work on device validation. In this paper, we, therefore, list
currently used metrics and propose new ones in case of
gaps for experimental validation of such devices. We believe
that homogeneous reporting of validation results will help
selecting the best approach for all clinical scenarios. Hence,
this paper will form a major drive for clinical implementation
of new MR hyperthermia technologies and, hence, will
reduce one roadblock for achieving spatially and biologically
selective exploitation of the pallet of hyperthermia benefits.
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